Regional & State

Regional & State news.

Teva agreed to pay Kentucky more than $71 million to resolve allegations that marketing and promotional practices fueled the drug crisis. In addition to cash payments, Teva agreed to provide more than 23,000 units of Naloxone to Kentucky annually.